Papers and Presentations
How to use Search
You can use search for sourcing a variety of content on the CASSS website. CASSS makes available any content with author approval.
Refine Results
Filter By Content Type
Filter By Resource Type
Filter By Event Types
Filter By Tags
-
CMC North America 2022 Scientific Program
Scientific Program: CMC North America 2022
-
Manufacturing Challenges and Strategies for Bispecific Antibody
Speaker Presentation Wu Wen Jin CDER, FDA 2022
-
Expectations on Potency Assays for Antibody-based Novel Modalities– a Regulatory Perspective
Speaker Presentation Zhang Nailing CDER, FDA 2022
-
A Potent Solution to a
Low Affinity Problem
Speaker Presentation Wilson Morgan INHIBRX 2022
-
Characterization of Novel Biological Product Modalities - A Regulatory Perspective
Speaker Presentation Rivera Rosado Leslie CDER, FDA 2022
-
Novel Modalities May Warrant Novel Product Quality Controls
Speaker Presentation Schmiel Deborah CDER, FDA 2022
-
Cell-Based Potency Assay : Designs and Considerations
Speaker Presentation Kumar Janani Molecular Templates, Inc. 2022
-
Leveraging a Novel Flexible Facility Concept to Provide Solutions to Current and Future Manufacturing Challenges
Speaker Presentation Christy Charles Lonza 2022
-
CMC Strategy Forum North America 2022 Summary Infographic
Summary Infographic: CMC Strategy Forum North America 2022
-
Stability Considerations and Challenges in Autologous Cell Therapy
Speaker Presentation Polson Nolan, Bristol-Myers Squibb Company, 2020
-
What Is Test Method Qualification?
CMC Summary Paper: CMC Strategy Forum North America Summer 2003
-
Defining Your Product Profile and Maintaining Control Over It - Part 1 through 4
CMC Summary Paper: CMC Strategy Forum North America Summer 2004
-
Design and Successful Implementation of a Stability Program for Biotechnology-Derived Products
CMC Summary Paper: CMC Strategy Forum North America Summer 2005
-
Standard Reference Materials for Biopharmaceutical Products: Strategies to Support Product and Method Specifications
CMC Summary Paper: CMC Strategy Forum North America Summer 2006
-
Quality by Design (QbD) for Biopharmaceuticals
CMC Summary Paper: CMC Strategy Forum North America Summer 2007
-
Practical Applications of Quality Risk Management
CMC Summary Paper: CMC Strategy Forum North America Summer 2009
-
QbD for Biologics: Learning's from the Product Development and Realization Case Study (A-Mab) and the FDA OBP Pilot Program
CMC Summary Paper: CMC Strategy Forum North America Summer 2010
-
Challenges and Considerations for Multiproduct Facility Design and Control for Biologics
CMC Summary Paper: CMC Strategy Forum North America Summer 2011
-
Drug Product for Biological Medicines: Novel Delivery Devices, Challenging Formulations and Combination Products - Part 1 and 2
CMC Summary Paper: CMC Strategy Forum North America Summer 2012
-
Biological Product-specific Reference Standard - Best Practices - Part 1 and 2
CMC Summary Paper: CMC Strategy Forum North America Summer 2013
CASSS On Demand
Access approved content from past meetings in the NEW CASSS On Demand platform. CASSS members have access to all available presentation recordings starting in April 2020. Visit https://ondemand.casss.org, login to your account, and select from the list of meetings to begin.